# Massimo Di Maïo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/massimo-di-maio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,502 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 67 |
| i10-index | 323 |
| Last Known Institution | Azienda Ospedaliera Citta' della Salute e della Scienza di Torino |
| OpenAlex ID | https://openalex.org/A5007575010 |
| ORCID iD | https://orcid.org/0000-0001-8906-3785 |
| Works | 772 |

## Researcher papers

- [Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data](https://scholariq.org/papers/carboplatin-or-cisplatin-based-chemotherapy-in-first-line-treatment-of-small/)
- [Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles](https://scholariq.org/papers/platinum-based-chemotherapy-in-advanced-non-small-cell-lung-cancer-optimal/)
- [First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial](https://scholariq.org/papers/first-line-erlotinib-followed-by-second-line-cisplatin-gemcitabine-chemotherapy/)
- [Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy](https://scholariq.org/papers/differential-influence-of-antibiotic-therapy-and-other-medications-on/)
- [First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status](https://scholariq.org/papers/first-line-pembrolizumab-in-advanced-non-small-cell-lung-cancer-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Azienda Ospedaliera Citta' della Salute e della Scienza di Torino](https://scholariq.org/institutions/azienda-ospedaliera-citta-della-salute-e-della-scienza-di-torino/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.